Health
SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 – Aju Business Daily
[Courtesy of SK Bioscience]SEOUL — SK Bioscience, a cooperation partner for South Koreas state project to develop COVID-19 vaccines, will immediately embark on…
[Courtesy of SK Bioscience]
SEOUL — SK Bioscience, a cooperation partner for South Korea’s state project to develop COVID-19 vaccines, will immediately embark on the first phase of clinical trials to evaluate the safety and immunogenicity of its vaccine candidate called NBP2001. The first test will be conducted on healthy adults at a state-run hospital.The Ministry of Food and Drug Safety said that SK Bioscience has been allowed to carry out clinical trials of NBP2001, a recombinant vaccine manufactured…
-
Noosa News23 hours agoBlute’s Bar Is Picking Up Where The Bearded Lady Left Off, Adding Live Music to Its Late-Night Karaoke Sing-Alongs
-
Noosa News24 hours agoBrawl at busy intersection at Ashmore on the Gold Coast ends in heavy fines
-
General22 hours agoIs Australia derivative? | The Spectator Australia
-
Noosa News23 hours agoThe 40 stitches that failed to stop Dolphins hooker Jeremy Marshall-King